Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3819 results

Sort By:

DIrect Oral Anticoagulation and Bioprothesis Aortic Valve

Study ID: NCT05687448
Start Date: 2025-09
End Date: 2029-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1500

Intervention / Treatment

Apixaban 5 MG Oral Tablet

Aspirin 75 to 100mg once a day

Sponsor

Public assistance - Paris hospitals

Source: clinicaltrials.gov

Share:
Add to list

Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics

Study ID: NCT06630273
Start Date: 2025-07-31
End Date: 2027-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment
Sponsor

Canadian Cancer Trials Group

Source: clinicaltrials.gov

Share:
Add to list

A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis.

Study ID: NCT05454566
Start Date: 2025-11-15
End Date: 2027-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

18

Intervention / Treatment

ICM-203

Sponsor

ICM Co. Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Essential Amino Acids and Parkinsons Disease

Study ID: NCT06604065
Start Date: 2026-01
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

15

Intervention / Treatment

AMS2434 (amino acids)

Placebo

Sponsor

University of Arkansas

Source: clinicaltrials.gov

Share:
Add to list

The Scandinavian Displaced Lateral Clavicle Trial

Study ID: NCT06981065
Start Date: 2025-08-15
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

96

Intervention / Treatment

Simple Sling and Physiotherapy

Surgical treatment

Sponsor

Uppsala University

Source: clinicaltrials.gov

Share:
Add to list

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Study ID: NCT06769126
Start Date: 2025-09-08
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

900

Intervention / Treatment

Biospecimen Collection

Ceralasertib

Computed Tomography

Durvalumab

Etoposide

Magnetic Resonance Imaging

Monleejumb

Platinum Compound

Positron Emission Tomography

Saruparib

Thoracic Radiation Therapy

Sponsor

SWOG Cancer Research Network

Source: clinicaltrials.gov

Share:
Add to list

Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer

Study ID: NCT07034365
Start Date: 2025-08
End Date: 2027-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment

No intervention

Sponsor

Fudan University

Source: clinicaltrials.gov

Share:
Add to list

A Study of Iguratimod in Combination With Tofacitinib in RA Patients

Study ID: NCT06945666
Start Date: 2025-08-01
End Date: 2027-05-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

200

Intervention / Treatment

Combined therapy of Iguratimod and tofacitinib

Sponsor

J IE Chang

Source: clinicaltrials.gov

Share:
Add to list

THC + CBD and Memory Study

Study ID: NCT04855526
Start Date: 2025-12-01
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

9

Intervention / Treatment

High THC/No CBD Marihuana

High THC/High CBD Marihuana

No THC/No CBD Marihuana

Sponsor

Hartford Hospital

Source: clinicaltrials.gov

Share:
Add to list

Effect of an Experimental Cannabidiol Gel on Tooth Sensitivity

Study ID: NCT07027566
Start Date: 2025-07-25
End Date: 2026-07
Study Type

Interventional

Study Phase

Phase1

No. of Participants

75

Intervention / Treatment

Potassium nitrate and sodium fluoride

Cannabidiol (CBD) Gel

Natrosol 4% Gel

Sponsor

Federal University of

Source: clinicaltrials.gov

Share:
Add to list